Viewing Study NCT02498912

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 10:44 PM

Ignite Modification Date: 2025-12-26 @ 10:44 PM

Study NCT ID: NCT02498912

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-07-31

First Post: 2015-07-10

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors

Sponsor: Memorial Sloan Kettering Cancer Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module